Santhera Pharmaceuticals Opens of U.S. Office in Burlington, MA; Appoints Todd Bazemore to Lead U.S. Operations in Burlington, MA

Santhera Pharmaceuticals announced that it will be establishing U.S. operations in Burlington, Mass.

Santhera's U.S. operations are being led by Todd Bazemore, Chief Operating Officer of Santhera Pharmaceuticals (USA) Inc. The U.S. operations will initially be staffed to focus on regulatory and clinical operations support, medical affairs, patient advocacy liaison and commercial strategy.